Requesting Peramivir IV Under Emergency Use Authorization (EUA)

You are initiating a request for Peramivir IV, an unapproved (investigational) product. Clinicians considering Peramivir IV under EUA must read and understand the content of the FDA-issued Emergency Use Authorization of Peramivir IV: Fact Sheet For Health Care Providers prior to initiating a request and must agree to comply with terms and conditions of authorized use of Peramivir IV per the FDA-issued EUA in order to successfully complete and transmit the request for this product.

You will be required to acknowledge your compliance with the terms and conditions of the EUA in order to request Peramivir IV.

If you do not wish to request Peramivir IV, please click here to return to the previous screen.

Please be informed that each Peramivir IV request is for one course of therapy. 

Once your completed electronic request has been successfully submitted, acknowledgment will be sent to the email you provide. Once the received request has been accepted and processed, you will be notified via email. It may take up to 24 hours, once the decision to ship Peramivir IV is made, for the product to reach the indicated delivery location (i.e., hospital pharmacy).